Table 2 of Horie, Mol Vis 2009; 15:1115-1119.


Table 2. Genotype frequencies in VKH patients and controls.


SNP

Allele
VKH
(n=168)

Percentage
Control
(n=187)

Percentage
Odds ratio
(95% CI)

p
rs3811021 C/C 2 1.2 9 4.8 0.24 (0.05–17.47) 0.05
T/C 56 33.5 67 35.8 0.90 (0.58–7.38) 0.65
T/T 109 65.3 111 59.4 1.29 (0.84–7.53) 0.25
C 60
85
0.75 (0.51–7.41) 0.12
rs1217413 A/A 26 16 36 19.4 0.79 (0.45–7.63) 0.41
A/G 77 47.2 91 48.9 0.93 (0.61–7.43) 0.75
G/G 60 36.8 59 31.7 1.25 (0.80–7.56) 0.32
A 129
163
0.84 (0.62–7.25) 0.26
rs1237682 C/C 26 15.5 33 18.4 0.83 (0.47–7.63) 0.53
T/C 79 47 89 49.7 0.94 (0.62–7.34) 0.77
T/T 59 35.1 57 31.8 1.20 (0.77–7.53) 0.42
C 131
155
0.87 (0.64–7.24) 0.37
rs3761935 G/G 3 1.8 10 5.3 0.33 (0.09–12.76) 0.08
T/G 55 33.3 67 35.8 0.90 (0.58–7.39) 0.62
T/T 107 64.8 110 58.8 1.29 (0.84–7.54) 0.25
G 61
87
0.75 (0.52–7.41) 0.12
rs3789608 T/T 2 1.2 9 4.8 0.24 (0.05–17.57) 0.05
C/T 57 34.1 68 36.4 0.91 (0.59–7.38) 0.66
C/C 108 64.7 110 58.8 1.26 (0.82–7.50) 0.29
T 61
86
0.74 (0.51–7.41) 0.11
rs2243471 A/A 27 16.7 37 20.2 0.79 (0.46–7.62) 0.4
A/G 79 48.8 88 48.1 1.03 (0.67–7.36) 0.9
G/G 56 34.6 58 31.7 1.14 (0.73–7.48) 0.57
A 133
162
0.88 (0.65–7.24) 0.39